文献速递乳腺MR

扩散加权成像与动态对比增强MRI:可疑乳腺病变表征的新视野

Diffusion-weighted imaging versus dynamic contrast-enhanced MRI: a new horizon for characterisation of suspicious breast lesions.
PubMed 文献 · Clin Radiol · 2020-10-17

该前瞻性研究纳入40例经超声-乳腺X线摄影按美国放射学会分类评估为可疑乳腺病变的女性患者,所有患者行常规MRI、DWI、DTI及纤维束示踪成像(FT),以动态对比增强MRI为参考标准,最终诊断经组织病理学证实。恶性病变32/40例(80%),良性8/40例(20%);恶性病变ADC值在截断值0.99±0.07×10⁻³ mm²/s下显著低于良性病变(p<0.001),FA值在恶性截断值0.19±0.05下亦显著低于良性病变(p<0.005);联合DTI与FT的敏感度、特异度和准确度与DCE MRI相似(p<0.001)。

要点

  • 恶性乳腺病变ADC值显著低于良性病变,截断值0.99±0.07×10⁻³ mm²/s(p<0.001)。
  • 恶性乳腺病变FA值显著低于良性病变,截断值0.19±0.05(p<0.005)。
  • 联合DTI与FT的敏感度、特异度和准确度与DCE MRI相似(p<0.001)。

诊断标准与关键数值

  • 恶性病变ADC值在截断值0.99±0.07×10⁻³ mm²/s下显著低于良性病变(p<0.001)。
  • 恶性病变FA值在恶性截断值0.19±0.05下显著低于良性病变(p<0.005)。
  • 联合DTI与FT的敏感度、特异度和准确度与DCE MRI相似(p<0.001)。

临床应用与阅片要点

  • 作者认为DTI和FT作为DWI的新应用,在评估可疑乳腺肿块方面显示出有前景的结果,能以统计学显著性区分良恶性病变,表现接近对比增强MRI。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

AIM: To investigate the value of new diffusion-weighted imaging applications in the characterisation of suspicious breast lesions with emphasis on diffusion tensor imaging (DTI) and fibre tractography (FT).

MATERIALS AND METHODS: The present prospective study included 40 female patients with suspicious breast lesions according to sono-mammography American College of Radiologists' classification. All patients underwent conventional magnetic resonance imaging (MRI), diffusion-weighted imaging (DWI), DTI, and FT after meeting the inclusion criteria. Dynamic contrast-enhanced MRI was performed as the reference standard for radiological evaluation. The study was conducted between August 2018 and January 2019. The final diagnosis was confirmed histopathologically.

RESULTS: Malignant lesions were diagnosed in 32/40 (80%) patients and 8/40 (20%) patients had benign lesions. Apparent diffusion coefficient (ADC) values of malignant lesions were statistically lower than that of benign lesions (p<0.001) using a cut-off value of 0.99±0.07×10-3 mm2/s. Fractional anisotropy (FA) values were lower in malignant lesions than in benign lesions with a cut-off value for malignancy of 0.19±0.05 and were statistically significant (p<0.005). The sensitivity, specificity, and accuracy of combined DTI and FT were similar to DCE MRI (p<0.001).

CONCLUSION: DTI and FT are new applications of DWI. They show promising results for the evaluation of suspicious breast masses and can distinguish between benign and malignant breast lesions with statistical significance approaching contrast-enhanced MRI, which is considered the imaging reference standard for characterising breast lesions.

来源:Clin Radiol,查看原文。版权归原作者所有。

引用

  1. El Ameen NF, Abdel Gawad EA, Abdel Ghany HS, et al. Diffusion-weighted imaging versus dynamic contrast-enhanced MRI: a new horizon for characterisation of suspicious breast lesions. Clin Radiol. 2020. PMID: 33077159. doi:10.1016/j.crad.2020.08.031

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。